Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660–4.

Article  PubMed  PubMed Central  Google Scholar 

Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. The Lancet [Internet]. 2017;370(9590):890–907. https://doi.org/10.1016/S0140-6736(07)61416-0.

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2024; https://acsjournals.onlinelibrary.wiley.com/doi/https://doi.org/10.3322/caac.21834.

UNAIDS, Data. 2020. Programme on HIV/AIDS [Internet]. 2020;1–248. https://www.unaids.org/en/resources/documents/2020/unaids-data%0Ahttp://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf.

WHO (World Health Organisation). Globocan 2020: United Republic of Tanzania. Popul Policy Compend [Internet]. 2020;1–6. https://gco.iarc.fr/today/data/factsheets/populations/834-tanzania-united-republic-of-fact-sheets.pdf.

Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk Hum Papillomavirus – Assoc Cancers among Persons AIDS. 2009;101(16).

CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA. 1993;269:729–30.

Article  Google Scholar 

UNAIDS. HIV and AIDS Estimates Country factsheets UNITED REPUBLIC OF TANZANIA | 2022.

IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans, Human Papillomaviruses. Lyon: International Agency for Research on Cancer, 2012 [Internet]. Biological Agents, Vol. 100B, 2007;2005:255–95. http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B.pdf.

Baisley KJ, Andreasen A, Irani J, Nnko S, Changalucha J, Crucitti T, et al. HPV prevalence around the time of sexual debut in adolescent girls in Tanzania. Sex Transm Infect. 2020;96(3):211–9.

Article  PubMed  Google Scholar 

Dartell M, Rasch V, Kahesa C, Mwaiselage J, Ngoma T, Junge J, et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-Negative women in the General Population of Tanzania: the PROTECT study. Sex Transm Dis. 2012;39(3):201–8.

Article  PubMed  Google Scholar 

Chachage M, Parikh AP, Mahenge A, Bahemana E, Mnkai J, Mbuya W, et al. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa. AIDS. 2023;37(4):625–35.

Article  CAS  PubMed  Google Scholar 

Murenzi G, Tuyisenge P, Kanyabwisha F, Munyaneza A, Muhoza B, Kubwimana G et al. Type-specific persistence, clearance and incidence of high-risk HPV among screen-positive Rwandan women living with HIV. Infect Agent Cancer. 2021;16(1).

Mpunga T, Chantal Umulisa M, Tenet V, Rugwizangoga B, Milner DA, Munyanshongore C, et al. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status. Int J Cancer. 2020;146(6):1514–22.

Article  CAS  PubMed  Google Scholar 

Rad A, Sørbye SW, Dreyer G, Hovland S, Falang BM, Louw M et al. HPV types in cervical cancer tissue in South Africa. Med (United States). 2017;96(47).

Carlander C, Lagheden C, Eklund C, Kleppe SN, Dzabic M, Wagner P, et al. HPV types in cervical precancer by HIV status and birth region: a population-based register study. Cancer Epidemiol Biomarkers Prev. 2020;29(12):2662–8.

Article  PubMed  Google Scholar 

Okoye JO, Chukwukelu CF, Okekpa SI, Ogenyi SI, Onyekachi-Umah IN. In: Ngokere AA, editor. Racial Disparities Associated with the prevalence of Vaccine and Non-vaccine HPV types and multiple HPV infections between Asia and Africa: a systematic review and Meta-analysis. Asian Pacific Journal of Cancer Prevention. Volume 22. Asian Pacific Organization for Cancer Prevention; 2021. pp. 2729–41.

Pinheiro M, Gage JC, Clifford GM, Demarco M, Cheung LC, Chen Z, et al. Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention. Int J Cancer. 2020;147(10):2677–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clifford GM, Tully S, Franceschi S. Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clin Infect Dis. 2017;64(9):1228–35.

Article  PubMed  PubMed Central  Google Scholar 

Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV Vaccination and the risk of Invasive Cervical Cancer. N Engl J Med. 2020;383(14):1340–8.

Article  CAS  PubMed  Google Scholar 

Li AJ, Manzi F, Kyesi F, Makame Y, Mwengee W, Fleming M et al. Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019. Vaccine. 2022;40:A38–48.

Sanjose S, De, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. 2010;11(November):7–11.

Lijie, Cao, et al. Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer. Int J Gynecol Cancer. 2019;29(8):1244–51.

Article  Google Scholar 

Wang WP, et al. Prevalence and attribution of high-risk HPV in different histological types of cervical cancer. Zhonghua Fu Chan Ke Za Zhi. 2019;54(5):293–300.

CAS  PubMed  Google Scholar 

Ita, Hadzisejdć et al. Distribution of human papillomavirus types in different histological subtypes of cervical adenocarcinoma. Coll Antropol. 2007;97–102.

World Health Organization. WHO Female reproduction organs 2020. 2020.

Atila B. Genotype 15 High Risk HPV by Fluorescent Detection. 2019.

Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L et al. Human Papillomavirus Infection and Cervical Cytology in HIV-Infected and HIV‐Uninfected Rwandan Women. J Infect Dis [Internet]. 2009;199(12):1851–61. https://academic.oup.com/jid/article-lookup/doi/https://doi.org/10.1086/599123.

Sinayobye J, d’Amour, Sklar M, Hoover DR, Shi Q, Dusingize JC, Cohen M et al. Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda. Infect Agent Cancer [Internet]. 2014;9(1):40. http://infectagentscancer.biomedcentral.com/articles/https://doi.org/10.1186/1750-9378-9-40.

Murenzi G, Kanyabwisha F, Murangwa A, Kubwimana G, Mutesa L, Burk RD, et al. Twelve-year trend in the prevalence of high-risk human papillomavirus infection among Rwandan women living with HIV. J Infect Dis. 2020;222(1):74–81.

Article  PubMed  PubMed Central  Google Scholar 

Alemany L, Pérez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, et al. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention. Gynecol Oncol. 2012;124(3):512–7.

Article  PubMed  Google Scholar 

Burk RD, Chen Z, Saller C, Tarvin K, Carvalho AL, Scapulatempo-Neto C, et al. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378–84.

Article  CAS  Google Scholar 

Iljazović E, Mena M, Tous S, Alemany L, Omeragić F, Sadiković A, et al. Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina. Cancer Epidemiol. 2014;38(5):504–10.

Article  PubMed  Google Scholar 

de Sanjose S, Klaustermeier JE, Lloveras B, Tous S, Guimera N, Clavero O, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol [Internet]. 2010;11:1048–56. Available from: www.thelancet.com/oncology.

Article  PubMed  Google Scholar 

ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, et al. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer. 1992;51(4):515–21.

Article  CAS  PubMed  Google Scholar 

Du J, Näsman A, Carlson JW, Ramqvist T, Dalianis T. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination. Acta Oncol (Madr). 2011;50(8):1215–9.

Article  Google Scholar 

Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621–32.

Article  CAS  PubMed  Google Scholar 

Neerja, Bhatla, et al. Human papillomavirus type distribution in cervical cancer in Delhi, India. Int J Gynecol Pathol. 2006;25(4):398–402.

Article  Google Scholar 

Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer. 1996;77(11):2275–9.

Article  CAS  PubMed  Google Scholar 

Barnabas RV, Brown ER, Onono M, Bukusi EA, Njoroge B, Winer RL et al. Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE study): study protocol for a randomized controlled trial. Trials. 2021;22(1).

Barnabas RV, Brown ER, Onono MA, Bukusi EA, Njoroge B, Winer RL et al. Efficacy of single-dose human papillomavirus vaccination among young African women. NEJM Evid. 2022;1(5).

Merck. News Release Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL ® 9.

Zhu FC, Zhong GH, Huang WJ, Chu K, Zhang L, Bi ZF, et al. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial. Lancet Infect Dis. 2023;23(11):1313–22.

Article  CAS  PubMed  Google Scholar